Universal preprocedural SARS-CoV-2 testing protocol within a large healthcare system | Zendy

John J. Squiers | Zendy; Shekhar Ghamande | Zendy; Taoran Qiu | Zendy; Chessie Robinson | Zendy; C Bertschy | Zendy; Alejandro C. Arroliga | Zendy; Walter R. Peters | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Universal preprocedural SARS-CoV-2 testing protocol within a large healthcare system

Author(s) -

John J. Squiers,

Shekhar Ghamande,

Taoran Qiu,

Chessie Robinson,

C Bertschy,

Alejandro C. Arroliga,

Walter R. Peters

Publication year - 2021

Publication title -

british journal of surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.202

H-Index - 201

eISSN - 1365-2168

pISSN - 0007-1323

DOI - 10.1093/bjs/znab216

Subject(s) - medicine , covid-19 , asymptomatic , protocol (science) , transmission (telecommunications) , health care , test (biology) , diagnostic test , healthcare system , point of care testing , medical emergency , emergency medicine , virology , surgery , disease , pathology , alternative medicine , infectious disease (medical specialty) , paleontology , economic growth , outbreak , electrical engineering , economics , biology , engineering

This research letter details the safety of a universal asymptomatic preprocedural SARS-CoV-2 testing protocol implemented within a large, integrated healthcare system. Among over 145 000 tests administered, fewer than 1 in 1000 patients had subsequent positive tests within 10 days of an initial negative SARS-CoV-2 test. Despite the infrequency of positive tests after negative screening tests, patient-to-provider transmission was documented in five instances.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research